Androxy Related Published Studies
Well-designed clinical trials related to Androxy (Fluoxymesterone)
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52. [2006.07]
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age. [2000.05]
Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. [1999.10]
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis. [1991.02.15]
Tamoxifen and fluoxymesterone versus tamoxifen and danazol in metastatic breast cancer--a randomized study. [1988.09]
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer. [1988.05]
Well-designed clinical trials possibly related to Androxy (Fluoxymesterone)
Comparison of chemotherapy with chemohormonal therapy as first-line therapy for metastatic, hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group study. [2000.01]
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment. [1998.05]
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. [1997.03.15]
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. [1996.05.15]
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. [1996.05]
Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281. [1995.06]
Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study. [1994.01]
Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study. [1991.12]
[Role of supporting therapy of Juzentaiho-to (JTT) in advanced breast cancer patients] [1989.04]
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome. [1988.09]
Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer. [1987]
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature. [1987]
Other research related to Androxy (Fluoxymesterone)
Long-term results of treatment with low-dose fluoxymesterone in constitutional delay of growth and puberty and in genetic short stature. [1993.04]
Fluoxymesterone as third line endocrine therapy for advanced breast cancer. A phase II trial of the Piedmont Oncology Association. [1992.06]
Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group Study. [1989.10.01]
[A case of Kennedy-Alter-Sung syndrome associated with external ophthalmoplegia--therapeutic efficacy of fluoxymesterone] [1989.02]
Effect of fluoxymesterone therapy on semen quality in the treatment of subfertile men. [1987]
Other possibly related research studies
Sample size calculations for the two-sample problem using the multiplicative intensity model. [2001.02.28]
Rat liver lysosomal and mitochondrial activities are modified by anabolic-androgenic steroids. [1999.02]
[Paroxysmal nocturnal hemoglobinuria] [1998.02.01]
Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer: still a question? [1998.02]
Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181). [1998.02]
Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications. [1997.04]
Survey of the hormones used in cattle fattening based on the analysis of Belgian injection sites. [1994.12]
Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer. [1994.08.15]
Adult height in girls with Turner syndrome treated with low-dose estrogens and androgens. [1994.05]
Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases. [1994.05]
[Action mechanism of synthetic androgens] [1994.03]
[Erythroblastopenia: chronic idiopathic or associated with chronic lymphoid leukemia. Value of cultures of erythroblastic progenitors and therapeutic strategy] [1993.06.26]
Effect of conventional dose growth hormone therapy for two years on height velocity and height prognosis in girls with Turner syndrome. [1993]
Sex hormones in juvenile nasopharyngeal angiofibroma tissue. [1993]
Deflazacort and fluoximesterone in advanced, pretreated breast cancer. [1992.08.31]
A pilot trial of chemohormonal therapy for metastatic prostate carcinoma. [1992.01.01]
Treatment of metastatic breast cancer and its complications. [1991.12]
The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer. [1991.08.01]
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial. [1991.08]
Androgen in the treatment of refractory anemia. [1991.04]
[Acute myelomegakaryocytic leukemia developed from myelodysplastic syndrome after chemotherapy against complicated small cell lung cancer] [1991.03]
pS2 expression and response to hormonal therapy in patients with advanced breast cancer. [1991.01.15]
[Allopurinol induced aplastic anemia in a patient with chronic renal failure] [1990.08]
Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer. [1989.11.01]
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. [1989.11]
Effect of long-acting gonadotropin-releasing hormone analog (leuprolide) therapy on prostatic size and symptoms in 15 men with benign prostatic hypertrophy. [1989.09]
Response of eccrine adenocarcinoma to tamoxifen. [1989.07.15]
Androgens directly stimulate proliferation of bone cells in vitro. [1989.03]
Turner syndrome: effect of hormone therapies on height velocity and adult height. [1988.09]
Hemostatic effects of hormonal stimulation in patients with metastatic prostate cancer. [1988.07]
Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum. [1988.04]
Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer. [1988]
Varicocele: medical and surgical treatment. [1987.11]
Artificial insemination (A.I.H.) for sperm antibodies and oligozoospermia. [1976.12]
Mini-dose of thalidomide for treatment of primary myelofibrosis. Report of a case with complete reversal of bone marrow fibrosis and splenomegaly. [2007.02]
|
